Filing Details
- Accession Number:
- 0001209191-22-013323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-25 18:31:11
- Reporting Period:
- 2022-02-23
- Accepted Time:
- 2022-02-25 18:31:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Medical Laboratories (8071) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1263312 | A Jacob Orville | C/O Exact Sciences Corp. 5505 Endeavor Lane Madison WI 53719 | General Manager, New Ventures | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-23 | 10,197 | $0.00 | 19,754 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-24 | 4,717 | $70.10 | 15,037 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Units | Disposition | 2022-02-23 | 10,197 | $0.00 | 10,197 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 312 | Indirect | Held in 401(k) Plan |
Footnotes
- Represents shares of common stock received upon vesting of a restricted stock unit award.
- Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 23, 2022.
- In addition to the shares of Common Stock reported on this Form 4, which total 15,349 shares, Mr. Orville also holds, in the aggregate, an additional 21,035 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- Each Performance Share Unit represents a right to receive one share of common stock.
- The PSU Award was subject to certain performance-based vesting requirements for the three-year period ending December 31, 2021.
Billionaire Hedge Funds
